SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 26, 2003

Robbins & Myers, Inc.

(Exact name of Registrant as specified in its charter)

Ohio	0-288	31-0424220
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(IRS Employer Identification No.)

1400 Kettering Tower, Dayton, OH (Address of principal executive offices) 45423(Zip code)

937-222-2610

(Registrant’s telephone number including area code)

Not applicable

(Former name and former address, if changed since last report)

TABLE OF CONTENTS

Item 5.  Other Events and Regulation FD Disclosure

On June 26, 2003, Robbins & Myers, Inc. issued the following press release:

ROBBINS & MYERS ANNOUNCES
HIGHER THIRD QUARTER OPERATING RESULTS

DAYTON, OHIO, June 26, 2003.... Robbins & Myers, Inc. (RBN) today announced its financial results for the third quarter ended May 31, 2003 which reflected solid improvement over the same period of the previous year and, also, a continuing quarter-to-quarter sequential gain this fiscal year. Diluted earnings per share of $.30 for the quarter were within the Company’s previously announced guidance.

Sales for the current quarter were $144.9 million, a 16% increase above the $124.8 million reported for the third quarter of fiscal 2002. Quarterly net income was $4.4 million versus $2.7 million for the same period, an increase of 63% from fiscal 2002. Diluted earnings per share for the third quarter were $.30 and $.23 for fiscal 2003 and 2002, respectively. Third quarter EBIT improved 21% to $11.4 million as compared with the $9.4 million reported for the same period of last fiscal year. Results for the third quarter represented the second consecutive quarter of sequential quarter-to-quarter improvement in sales and earnings.

Sales for the nine months ended May 31, 2003 were $403.9 million as compared with $394.2 million for the same period of fiscal 2002. Net income for the nine month period of this fiscal year was $9.4 million as compared with $12.3 million for the same period of 2002. Diluted earnings per share for the first nine months of fiscal 2003 and 2002 were $.66 and $.99, respectively. Year-to-date EBIT was $27.3 million versus $33.2 million for the same period last fiscal year.

Gerald L. Connelly, President and Chief Executive Officer of Robbins & Myers, Inc., stated, “Our performance this quarter reflects not only gains over the same period of last fiscal year but also a continuation of the favorable quarter-to-quarter improvement

reported earlier this fiscal year which includes benefits from a strengthening of the Euro. Sales increased 8% and earnings increased 29% sequentially over the second quarter.”

Connelly continued, “Our focus on cash management continues to produce positive results. We generated $17.1 million of cash flow from operations, less capital expenditures, during the most recent quarter. Year-to-date cash flow from operations, less capital expenditures, was $29.6 million, a 63% increase over the first nine months of last fiscal year.

Sales of the Company’s Pharmaceutical Segment were up 10% sequentially over the second quarter and 20% above the same period of the previous fiscal year. EBIT for this segment reflected strong improvement both sequentially and year-over-year. Contribution to this financial performance came from both the Company’s Reactor Systems and Romaco units.

The Energy Segment experienced a 7% increase in sales and a 10% increase in EBIT over the same quarter of last fiscal year. The energy market continues to remain stable with no appreciable increase in capital spending taking place to date.

The Industrial Segment financial results improved in the quarter with a 10% sequential and 12% year-over-year improvement in sales. Substantial gains in EBIT both sequentially and year-over-year were recorded for this segment. This segment’s three business units, Chemineer, Edlon and Moyno all contributed to the improvement.

Connelly concluded, “We will remain focused on cash management and continued improvement of our cost structure. This fiscal year continues to be challenging with the unsettled economic conditions worldwide. Diluted earnings per share for fiscal year 2003 are anticipated to be in the range of $1.00 to $1.05. Looking forward, the Company is well positioned for earnings improvement as its markets strengthen.”

The Company also announced that its Board of Directors approved a regular quarterly dividend of $.055 per share (annual rate $.22) and is payable July 31, 2003 to shareholders of record as of July 11, 2003.

Conference Call

Robbins & Myers, Inc. has scheduled a conference call and webcast for 11:00 a.m./EDT on Thursday, June 26, 2003 to review the third quarter and nine months results. Please contact the Company’s Investor Relations to register for the call. The webcast of the call is available at the Company’s website at www.robbinsmyers.com.

Robbins & Myers, Inc. is a leading global supplier of highly-engineered, application-critical equipment for the pharmaceutical, energy, and industrial markets. Headquartered in Dayton, Ohio the Company has manufacturing facilities in the United States, Canada, Europe, Brazil, Mexico, Singapore, Venezuela, Australia, China, France, India, and Taiwan.

In addition to historical information, this release contains forward-looking statements, identified by use of words such as “expects,” “anticipates,” “estimates,” and similar expressions. These statements reflect the Company’s expectations at the time this release was issued. Actual results may differ materially from those described in the forward-looking statements. Among the factors that could cause material differences are a significant decline in capital expenditures in specialty chemical and pharmaceutical industries, a major decline in oil and natural gas prices, foreign exchange rate fluctuations, continued availability of acceptable acquisition candidates and general economic conditions that can affect demand in the process industries. The Company undertakes no obligation to update or revise any forward-looking statement.

The Company’s common stock trades on the New York Stock Exchange under the symbol RBN.

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET
     (Unaudited)

(in thousands)				May 31, 2003		August 31, 2002
ASSETS
	Current Assets:
		Cash and cash equivalents		$	9,196	$	10,534
		Accounts receivable			113,089		113,711
		Inventories			104,668		92,446
		Other current assets			10,933		12,318
		Deferred taxes			13,607		14,071
			Total Current Assets		251,493		243,080
	Goodwill & Other Intangible Assets				319,556		289,552
	Other Assets				6,991		6,201
	Property, Plant & Equipment				147,193		143,859
				$	725,233	$	682,692
LIABILITIES AND SHAREHOLDERS’ EQUITY
	Current Liabilities:
		Accounts payable		$	48,464	$	41,964
		Accrued expenses			85,810		83,871
		Current portion of long-term debt			7,346		4,526
			Total Current Liabilities		141,620		130,361
	Long-Term Debt — Less Current Portion				192,658		203,920
	Deferred Taxes				8,827		8,708
	Other Long-Term Liabilities				88,391		79,210
	Shareholders’ Equity				293,737		260,493
				$	725,233	$	682,692

Note: All known adjustments have been reflected in this report, but the information is subject to annual audit and year-end adjustments which are estimated to be insignificant.

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENT
     (Unaudited)

		Three Months Ended				Nine Months Ended
		May 31,		May 31,		May 31,		May 31,
(in thousands, except per share data)		2003		2002		2003		2002
Sales		$	144,921	$	124,812	$	403,904	$	394,201
Cost of sales			95,782		83,419		267,970		262,342
Gross profit			49,139		41,393		135,934		131,859
SG&A expenses			37,146		31,640		106,938		97,073
Amortization expense			554		388		1,664		1,569
Other			0		0		0		0
Income before interest and income taxes			11,439		9,365		27,332		33,217
Interest expense			4,000		4,909		11,710		13,528
Income before income taxes and minority interest			7,439		4,456		15,622		19,689
Income tax expense			2,488		1,490		5,230		6,590
Minority interest			540		270		948		792
Net income		$	4,411	$	2,696	$	9,444	$	12,307
Net Income Per Share:
	Basic	$	0.31	$	0.23	$	0.66	$	1.04
	Diluted	$	0.30	$	0.23	$	0.66	$	0.99
Weighted Average Common Shares Outstanding:
	Basic		14,373		11,894		14,358		11,833
	Diluted		16,534		14,203		16,581		14,162
Orders		$	137,792	$	139,969	$	418,969	$	380,895
Backlog		$	141,513	$	130,092	$	141,513	$	130,092

Note: All known adjustments have been reflected in this report, but the information is subject to annual audit and year-end adjustments which are estimated to be insignificant.

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONDENSED BUSINESS SEGMENT INFORMATION
     (Unaudited)

		Three Months Ended						Nine Months Ended
		May 31,			May 31,			May 31,			May 31,
(in thousands)		2003			2002			2003			2002
Sales
	Pharmaceutical	$	88,028		$	73,071		$	243,336		$	235,854
	Industrial		33,419			29,801			91,726			89,971
	Energy		23,474			21,940			68,842			68,376
	Total	$	144,921		$	124,812		$	403,904		$	394,201
Income Before Interest and Income Taxes (EBIT)
	Pharmaceutical	$	6,149		$	5,365		$	14,262		$	22,718
	Industrial		3,100			2,014			7,270			4,747
	Energy		4,914			4,483			14,436			13,573
	Corporate and Eliminations		(2,724	)		(2,497	)		(8,636	)		(7,821	)
	Total	$	11,439		$	9,365		$	27,332		$	33,217
Depreciation and Amortization
	Pharmaceutical	$	2,877		$	2,583		$	8,181		$	7,917
	Industrial		1,340			1,091			3,815			4,106
	Energy		1,432			1,324			4,216			4,162
	Corporate and Eliminations		356			235			1,040			670
	Total	$	6,005		$	5,233		$	17,252		$	16,855
Orders
	Pharmaceutical	$	81,049		$	91,004		$	255,460		$	233,184
	Industrial		33,351			27,789			94,857			82,363
	Energy		23,392			21,176			68,652			65,348
	Total	$	137,792		$	139,969		$	418,969		$	380,895
Backlog
	Pharmaceutical	$	113,972		$	105,374		$	113,972		$	105,374
	Industrial		24,405			20,253			24,405			20,253
	Energy		3,136			4,465			3,136			4,465
	Total	$	141,513		$	130,092		$	141,513		$	130,092

Note: All known adjustments have been reflected in this report, but the information is subject to annual audit and year-end adjustments which are estimated to be insignificant.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Robbins & Myers, Inc.

Date: June 26, 2003 By: /s/ Kevin J. Brown Kevin J. Brown
Vice President and Chief Financial Officer